Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. provides omni-channel pharmaceutical distribution services in China. It is involved in pharmaceutical B2B e-commerce, production, wholesale, and retail businesses, as well as provides logistics services. It offers Western medicine, Chinese patent medicine, Chinese herbal medicine slices and Chinese medicinal materials, food and health f… Read more
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. (300937) - Total Liabilities
Latest total liabilities as of June 2025: CN¥930.16 Million CNY
Based on the latest financial reports, Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. (300937) has total liabilities worth CN¥930.16 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. - Total Liabilities Trend (2019–2024)
This chart illustrates how Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ningbo Homelink Eco-iTech Co. Ltd.
SHE:301193
|
China | CN¥3.52 Billion |
|
Guangdong Liantai Environmental Protection Co Ltd
SHG:603797
|
China | CN¥6.52 Billion |
|
SAMCO Inc
F:SMU
|
Germany | €4.10 Billion |
|
Hy-Lok Corporation
KQ:013030
|
Korea | ₩37.86 Billion |
|
Astral Foods Limited
PINK:ALFDF
|
USA | $3.95 Billion |
|
JMT Network Services Public Company Limited
BK:JMT
|
Thailand | ฿10.00 Billion |
|
Ocean’s King Lighting Science & Technology Co Ltd
SHE:002724
|
China | CN¥581.18 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. (2019–2024)
The table below shows the annual total liabilities of Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥865.81 Million | +4.19% |
| 2023-12-31 | CN¥831.02 Million | +7.70% |
| 2022-12-31 | CN¥771.64 Million | +93.33% |
| 2021-12-31 | CN¥399.13 Million | +24.96% |
| 2020-12-31 | CN¥319.42 Million | +24.51% |
| 2019-12-31 | CN¥256.54 Million | -- |